OM
Outset medical Inc
$18.4
Earnings Summary
Revenue | $25.22Mn |
Net Profits | $-30.21Mn |
Net Profit Margins | -119.8% |
Highlights
Outset medical Inc’s revenue jumped 114.75% since last year same period to $25.22Mn in the Q2 2021. On a quarterly growth basis, Outset medical Inc has generated 10.04% jump in its revenue since last 3-months.
Outset medical Inc’s net profit fell -13.97% since last year same period to $-30.21Mn in the Q2 2021. On a quarterly growth basis, Outset medical Inc has generated -0.61% fall in its net profits since last 3-months.
Outset medical Inc’s net profit margin jumped 46.93% since last year same period to -119.8% in the Q2 2021. On a quarterly growth basis, Outset medical Inc has generated 8.57% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Outset medical Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.8 |
EPS Estimate Current Year | -0.8 |
Highlights
Outset medical Inc’s earning per share (EPS) estimates for the current quarter stand at -0.8 - a 1.23% jump from last quarter’s estimates.
Outset medical Inc’s earning per share (EPS) estimates for the current year stand at -0.8.
Key Ratios
Key ratios of the Outset medical Inc post its Q4 2022 earnings
Return on Assets (ROA) | -0.23 |
Return on Equity (ROE) | -0.53 |
Highlights
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Outset medical Inc’s return on assets (ROA) stands at -0.23.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Outset medical Inc’s return on equity (ROE) stands at -0.53.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-11-09 | -0.81 | -0.85 | -4.94% |
2022-08-02 | -0.7 | -0.92 | -31.43% |
2022-05-05 | -0.72 | -0.78 | -8.33% |
Company Information
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
Organisation | Outset medical Inc |
Headquarters | 3052 Orchard Drive, San Jose, CA, United States, 95134 |
Employees | 518 |
Industry | Health Technology |
CEO | Leslie L. Trigg |
